Latest Conference Articles

June 4th 2016, 1:23am

ASCO Annual Meeting

The addition of capecitabine to standard adjuvant gemcitabine doubled 5-year overall survival (OS) rates for patients with pancreatic cancer whose tumors were surgically removed.

June 1st 2016, 7:41pm

ASCO Annual Meeting

Immunotherapy agents targeting the PD-1/PD-L1 pathway will be the most robust area for news at the 2016 ASCO Annual Meeting, but there will be much new data about recently approved and novel anticancer drugs for clinicians to digest.

May 31st 2016, 7:24pm

ASCO Annual Meeting

Research into 6 drugs scheduled to be presented during the upcoming 2016 ASCO Annual Meeting stand out as the most noteworthy abstracts on the docket this year because of their potential to influence clinical practice in the near future.

May 19th 2016, 3:11am

ASCO Annual Meeting

Forty percent of patients with advanced melanoma who started taking pembrolizumab during the clinical trial that led to its initial approval were still alive after 3 years, with many responders in remission even after stopping treatment.

May 19th 2016, 2:10am

ASCO Annual Meeting

Early findings from a phase III clinical trial suggest that patients with multiple myeloma who receive upfront autologous stem cell transplant survive longer without disease progression than those who receive chemotherapy alone.

May 19th 2016, 1:48am

ASCO Annual Meeting

Survival outcomes in patients with metastatic colorectal cancer were significantly longer among those with tumors originating on the left versus the right side of the colon, according to a retrospective analysis of the phase III 80405 trial.

May 19th 2016, 1:44am

ASCO Annual Meeting

Early palliative care integrated with oncology care benefits not only patients with cancer but also family caregivers.

May 19th 2016, 1:12am

ASCO Annual Meeting

Outcomes were significantly better in clinical trials that utilized a biomarker-based treatment selection strategy compared with non-personalized approaches.

May 12th 2016, 9:42am

AUA Annual Meeting

Krishna Vanaja Donkena, PhD, Assistant Professor of Biochemistry and Molecular Biology, Center for Individualized Medicine, Mayo Clinic, discusses using immune and checkpoint markers to predict cancer-specific survival in bladder cancer.

May 11th 2016, 4:55pm

AUA Annual Meeting

Major health policy implications follow findings from the landmark Prostate, Lung, Colorectal, and Ovary screening trial, after it was found that 80% of the control group reported at least one PSA test during the trial.

April 28th 2016, 8:05am

Oncology Nursing Society Congress

Dennise Geiger, RN, Regional Cancer Care Associates, Central Jersey Division, discusses difficulties nurses face when using telephone triage, and the plan that was developed to better streamline the process. 

April 28th 2016, 8:03am

Oncology Nursing Society Congress

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the concept she developed to manage dermatologic adverse events for patients with cancer.

April 28th 2016, 8:01am

Oncology Nursing Society Congress

When chemotherapy involves tricky infusion timing, patients are routinely admitted to hospitals to receive their treatments. But what would happen if these drugs could be administered successfully on an outpatient basis?

April 28th 2016, 8:01am

Oncology Nursing Society Congress

West Cancer Center researchers developed a best nursing practice protocol for titration of fentanyl sublingual spray, which is the most recently approved transmucosal immediate-release fentanyl formulation.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Researchers at the Rutgers Cancer Institute of New Jersey are testing the possibility of sending treatment drugs directly to the kidney in patients with upper urinary tract urothelial carcinoma.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

When oncology nurses move proactively to learn more about and use proven effective green-lighted interventions like exercise and muscle relaxation in their daily practice, it can go a long way.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

A multidisciplinary team led by oncology nurses can reduce both hospitalization and treatment breaks for patients with head and neck cancer.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, addresses common misconceptions that patients with cancer have about sleep disturbances.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Jeannine Brant, PhD, Billings Clinic, discusses the benefits of patient-reported outcomes in cancer care.

April 28th 2016, 8:00am

Oncology Nursing Society Congress

Cancer doesn’t discriminate, but that doesn’t mean the healthcare system won’t. This proves to be even more true for the lesbian, gay, bisexual and transgender community.